Theranostic role of89Zr/177Lu-labeled aflibercept in triple-negative breast cancer

被引:0
|
作者
Kang, L. [1 ]
Yang, Q. [1 ]
Chen, Z. [1 ]
Qiu, Y. [1 ]
Huang, W. [1 ]
Song, L. [1 ]
机构
[1] Peking Univ First Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-622
引用
收藏
页码:S282 / S283
页数:2
相关论文
共 50 条
  • [21] 177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer
    Salvanou, Evangelia-Alexandra
    Kolokithas-Ntoukas, Argiris
    Prokopiou, Danai
    Theodosiou, Maria
    Efthimiadou, Eleni
    Kozminski, Przemyslaw
    Xanthopoulos, Stavros
    Avgoustakis, Konstantinos
    Bouziotis, Penelope
    MOLECULES, 2024, 29 (05):
  • [22] 89Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy
    Yang, Rui
    Lu, Mudan
    Ming, Lan
    Chen, Yu
    Cheng, Kai
    Zhou, Jie
    Jiang, Shiwen
    Lin, Zhenyu
    Chen, Daozhen
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 9061 - 9074
  • [23] A Proof-of-Concept Study on the Theranostic Potential of 177Lu-labeled Biocompatible Covalent Polymer Nanoparticles for Cancer Targeted Radionuclide Therapy
    Chen, Xijian
    Tan, Fuyuan
    Liang, Ranxi
    Liao, Jiali
    Yang, Jijun
    Lan, Tu
    Yang, Yuanyou
    Liu, Ning
    Li, Feize
    CHEMISTRY-A EUROPEAN JOURNAL, 2024, 30 (09)
  • [24] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [25] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
    Savas, Peter
    Loi, Sherene
    CANCER CELL, 2020, 37 (05) : 623 - 624
  • [26] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [27] Triple-Negative Breast Cancer Role of the Androgen Receptor
    Gucalp, Ayca
    Traina, Tiffany A.
    CANCER JOURNAL, 2010, 16 (01): : 62 - 65
  • [28] Triple-Negative Breast Cancer Role of Antiangiogenic Agents
    Greenberg, Sally
    Rugo, Hope S.
    CANCER JOURNAL, 2010, 16 (01): : 33 - 38
  • [29] Role of mTOR inhibition in triple-negative breast cancer
    Massihnia, Daniela
    Bronte, Giuseppe
    Castiglia, Marta
    Barraco, Nadia
    Cangemi, Antonina
    Perez, Alessandro
    Fanale, Daniele
    Pantuso, Gianni
    Vieni, Salvatore
    Calo, Valentina
    Rolfo, Christian D.
    Bazan, Viviana
    Russo, Antonio
    CANCER RESEARCH, 2016, 76
  • [30] Role of flavonoids in inhibiting triple-negative breast cancer
    Wang, Shuai
    Wang, Kuanyu
    Li, Cheng
    Chen, Jing
    Kong, Xiangding
    FRONTIERS IN PHARMACOLOGY, 2024, 15